Sanofi Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: SAN and SNY), announced the expansion of its dengue vaccine clinical program in Latin America with a new multicenter study in children and adolescent in Mexico, Colombia, Honduras and Puerto Rico. This new multicenter study complements an earlier study in Mexico and an ongoing study in Peru. These studies are aimed at advancing the development of a novel vaccine for the prevention of dengue infections in Latin America…




Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded In Latin America

Sponsored by Internet Pharmacy - Indian Pharmacy, an online pharmacy supplies more than 600 quality generic medications, free prescription, worldwide shipping.

Canadian Pharmacy canada pharmacy

Related posts:

  1. Bharat Biotech Begins Phase I Clinical Trials Of HN-VAC – Its Cell Culture H1N1 Vaccine Bharat Biotech today announced that it has commenced Phase I clinical evaluation of HN-VAC, its cell culture based H1N1 vaccine candidate. Bharat Biotech received the nod from drugs Controller General...
  2. Condom Distribution Program In Los Angeles County Jail Might Be Expanded Condom Distribution Program In Los Angeles County Jail Might Be Expanded Los Angeles County Sheriff Lee Baca is considering expanding an eight-year-old program at Men’s Central Jail that distributes condoms...
  3. Sanofi-Aventis Buys Chattem for $1.9 Billion Sanofi-Aventis Buys Chattem for $1.9 Billion The French drug maker Sanofi-Aventis said Monday that it had agreed to buy the consumer health care company Chattem for about $1.9 billion, in...